Selective recruitment of host factors by HSV-1 replication centers

Feng-Chao LANG; Xin LI; Olga VLADMIROVA; Zhuo-Ran LI; Gui-Jun CHEN; Yu XIAO; Li-Hong LI; Dan-Feng LU; Hong-Bo HAN; Ju-Min ZHOU

Volume 36 Issue 3

May 2015

Turn off MathJax

Article Contents

Article Navigation > Zoological Research > 2015 > 36(3): 142-151

Feng-Chao LANG, Xin LI, Olga VLADMIROVA, Zhuo-Ran LI, Gui-Jun CHEN, Yu XIAO, Li-Hong LI, Dan-Feng LU, Hong-Bo HAN, Ju-Min ZHOU. Selective recruitment of host factors by HSV-1 replication centers. Zoological Research, 2015, 36(3): 142-151.

Citation:

PDF( 11592 KB)

Selective recruitment of host factors by HSV-1 replication centers

1 Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming Yunnan 650223, China;
2 University of Chinese Academy of Sciences, Beijing 100049, China;
3 The Wistar Institute, Gene Expression and Regulation Program, Philadelphia PA 19104, USA;
4 Biology & Chemistry Engineering College, Panzhihua University, Panzhihua Sichuan 617000, China

Funds: This work was supported by grants from the Yunnan Provincial Government (2013FA051; 2011HA005), the National Science Foundation of China (NSFC 81471966 to JZ and NSFC 31200964 to YX), and the common project of the Panzhihua Science and Technology Bureau from China (2012CY-S-22(9) to HH)

More Information

Corresponding author: Ju-Min ZHOU
Received Date: 2015-03-09
Rev Recd Date: 2015-04-09
Publish Date: 2015-05-08

Abstract

Abstract

Herpes simplex virus type 1 (HSV-1) enters productive infection after infecting epithelial cells, where it controls the host nucleus to make viral proteins, starts viral DNA synthesis and assembles infectious virions. In this process, replicating viral genomes are organized into replication centers to facilitate viral growth. HSV-1 is known to use host factors, including host chromatin and host transcription regulators, to transcribe its genes; however, the invading virus also encounters host defense and stress responses to inhibit viral growth. Recently, we found that HSV-1 replication centers recruit host factor CTCF but exclude γH2A.X. Thus, HSV-1 replication centers may selectively recruit cellular factors needed for viral growth, while excluding host factors that are deleterious for viral transcription or replication. Here we report that the viral replication centers selectively excluded modified histone H3, including heterochromatin mark H3K9me3, H3S10P and active chromatin mark H3K4me3, but not unmodified H3. We found a dynamic association between the viral replication centers and host RNA polymerase II. The centers also recruited components of the DNA damage response pathway, including 53BP1, BRCA1 and host antiviral protein SP100. Importantly, we found that ATM kinase was needed for the recruitment of CTCF to the viral centers. These results suggest that the HSV-1 replication centers took advantage of host signaling pathways to actively recruit or exclude host factors to benefit viral growth.
- HSV-1,
- CTCF,
- &gamma,
- H2AX,
- Viral replication cente,
- RNA Pol II

FullText(HTML)

References(67)

References

[1]	Bailey SG, Verrall E, Schelcher C, Rhie A, Doherty AJ, Sinclair AJ. 2009. Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1. Journal of Virology, 83(21): 11116-11122.
[2]	Barzilai A, Zivony-Elbom I, Sarid R, Noah E, Frenkel N. 2006. The herpes simplex virus type 1 vhs-UL41 gene secures viral replication by temporarily evading apoptotic cellular response to infection: Vhs-UL41 activity might require interactions with elements of cellular mRNA degradation machinery. Journal of Virology, 80(1): 505-513.
[3]	Burke LJ, Zhang R, Bartkuhn M, Tiwari VK, Tavoosidana G, Kurukuti S, Weth C, Leers J, Galjart N, Ohlsson R, Renkawitz R. 2005. CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin. The EMBO Journal, 24(18): 3291-3300.
[4]	Chaurushiya MS, Lilley CE, Aslanian A, Meisenhelder J, Scott DC, Landry S, Ticau S, Boutell C, Yates JR, 3rd, Schulman BA, Hunter T, Weitzman MD. 2012. Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain. Molecular Cell, 46(1): 79-90.
[5]	Conn KL, Schang LM. 2013. Chromatin dynamics during lytic infection with herpes simplex virus 1. Viruses, 5(7): 1758-1786.
[6]	Dai-Ju JQ, Li L, Johnson LA, Sandri-Goldin RM. 2006. ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection. Journal of Virology, 80(7): 3567-3581.
[7]	Egloff S, Murphy S. 2008. Cracking the RNA polymerase II CTD code. Trends in Genetics, 24(6): 280-288.
[8]	Esclatine A, Taddeo B, Evans L, Roizman B. 2004. The herpes simplex virus 1 U_L41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific. Proceedings of the National Academy of Sciences of the United States of America, 101(10): 3603-3608.
[9]	Everett RD. 2014. HSV-1 biology and life cycle. Methods in Molecular Biology, 1144: 1-17.
[10]	Everett RD, Murray J. 2005. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. Journal of Virology, 79(8): 5078-5089.
[11]	Everett RD, Sourvinos G, Leiper C, Clements JB, Orr A. 2004. Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. Journal of Virology, 78(4): 1903-1917.
[12]	Ferenczy MW, Ranayhossaini DJ, Deluca NA. 2011. Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1. Journal of Virology, 85(10): 4993-5002.
[13]	Filippova GN, Thienes CP, Penn BH, Cho DH, Hu YJ, Moore JM, Klesert TR, Lobanenkov VV, Tapscott SJ. 2001. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nature Genetics, 28(4): 335-343.
[14]	Fraser KA, Rice SA. 2007. Herpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase II. Journal of Virology, 81(10): 5091-5101.
[15]	Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K, Craigon MH, Chen R, Kaza LN, Fossum E, Fazakerley JK, Efstathiou S, Volpi A, Zimmer R, Ghazal P, Haas J. 2013. A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathogens, 9(8): e1003514.
[16]	Gu HD, Zheng Y, Roizman B. 2013. Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention. Journal of Virology, 87(18): 10244-10254.
[17]	Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GCM. 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Research, 64(24): 9152-9159.
[18]	Jenkins HL, Spencer CA. 2001. RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells. Journal of Virology, 75(20): 9872-9884.
[19]	Karttunen H, Savas JN, Mckinney C, Chen YH, Yates JR, 3rd, Hukkanen V, Huang TT, Mohr I. 2014. Co-opting the fanconi Anemia genomic stability pathway enables herpesvirus DNA synthesis and productive growth. Molecular Cell, 55(1): 111-122.
[20]	Klenova EM, Nicolas RH, Paterson HF, Carne AF, Heath CM, Goodwin GH, Neiman PE, Lobanenkov VV. 1993. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Molecular and Cellular Biology, 13(12): 7612-7624.
[21]	Knipe DM, Quinlan MP, Spang AE. 1982. Characterization of two conformational forms of the major DNA-binding protein encoded by herpes simplex virus 1. Journal of Virology, 44(2): 736-741.
[22]	Kwak H, Lis JT. 2013. Control of transcriptional elongation. Annual Review of Genetics, 47: 483-508.
[23]	Lacasse JJ, Schang LM. 2010. During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomes. Journal of Virology, 84(4): 1920-1933.
[24]	Lacasse JJ, Schang LM. 2012. Herpes simplex virus 1 DNA is in unstable nucleosomes throughout the lytic infection cycle, and the instability of the nucleosomes is independent of DNA replication. Journal of Virology, 86(20): 11287-11300.
[25]	Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A, Ying SW, Keros S, Goldstein PA, Mostoslavsky G, Ordovas-Montanes J, Jouanguy E, Plancoulaine S, Tu E, Elkabetz Y, Al-Muhsen S, Tardieu M, Schlaeger TM, Daley GQ, Abel L, Casanova JL, Studer L, Notarangelo LD. 2012. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature, 491(7426): 769-773.
[26]	Lai W, Chen CY, Morse SA, Htun Y, Fehler HG, Liu H, Ballard RC. 2003. Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sexually Transmitted Infections, 79(3): 202-207.
[27]	Lilley CE, Carson CT, Muotri AR, Gage FH, Weitzman MD. 2005. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proceedings of the National Academy of Sciences of the United States of America, 102(16): 5844-5849.
[28]	Lilley CE, Chaurushiya MS, Boutell C, Everett RD, Weitzman MD. 2011. The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathogens, 7(6): e1002084.
[29]	Lilley CE, Chaurushiya MS, Boutell C, Landry S, Suh J, Panier S, Everett RD, Stewart GS, Durocher D, Weitzman MD. 2010. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. The EMBO Journal, 29(5): 943-955.
[30]	Matsuoka S, Ballif BA, Smogorzewska A, Mcdonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao ZM, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316(5828): 1160-1166.
[31]	Mattiroli F, Vissers JHA, Van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, Marteijn JA, Sixma TK. 2012. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell, 150(6): 1182-1195.
[32]	Moon H, Filippova G, Loukinov D, Pugacheva E, Chen Q, Smith ST, Munhall A, Grewe B, Bartkuhn M, Arnold R, Burke LJ, Renkawitz-Pohl R, Ohlsson R, Zhou JM, Renkawitz R, Lobanenkov V. 2005. CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab-8 insulator. EMBO Reports, 6(2): 165-170.
[33]	Negorev DG, Vladimirova OV, Maul GG. 2009. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. Journal of Virology, 83(10): 5168-5180.
[34]	Nojima T, Oshiro-Ideue T, Nakanoya H, Kawamura H, Morimoto T, Kawaguchi Y, Kataoka N, Hagiwara M. 2009. Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Research, 37(19): 6515-6527.
[35]	(Roizman BK DM, Whitley RJ) Knipe DM, Howley PM. 2007. Fields Virology. 5^nd ed. Philadelphia, PA: Lippincott Williams & Wilkins.
[36]	Parkinson J, Lees-Miller SP, Everett RD. 1999. Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. Journal of Virology, 73(1): 650-657.
[37]	Pasieka TJ, Baas T, Carter VS, Proll SC, Katze MG, Leib DA. 2006. Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response. Journal of Virology, 80(15): 7600-7612.
[38]	Peng H, Nogueira ML, Vogel JL, Kristie TM. 2010. Transcriptional coactivator HCF-1 couples the histone chaperone Asf1b to HSV-1 DNA replication components. Proceedings of the National Academy of Sciences of the United States of America, 107(6): 2461-2466.
[39]	Prasad A, Remick J, Zeichner SL. 2013. Activation of human herpesvirus replication by apoptosis. Journal of Virology, 87(19): 10641-10650.
[40]	Rasmussen SB, Horan KA, Holm CK, Stranks AJ, Mettenleiter TC, Simon AK, Jensen SB, Rixon FJ, He B, Paludan SR. 2011. Activation of autophagy by α-herpesviruses in myeloid cells is mediated by cytoplasmic viral DNA through a mechanism dependent on stimulator of IFN genes. The Journal of Immunology, 187(10): 5268-5276.
[41]	Roizman B. 2011. The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex. Journal of Virology, 85(15): 7474-7482.
[42]	Roizman B, Whitley RJ. 2013. An inquiry into the molecular basis of HSV latency and reactivation. Annual Review of Microbiology, 67: 355-374.
[43]	Salsman J, Jagannathan M, Paladino P, Chan PK, Dellaire G, Raught B, Frappier L. 2012. Proteomic profiling of the human cytomegalovirus ul35 gene products reveals a role for UL35 in the DNA repair response. Journal of Virology, 86(2): 806-820.
[44]	Sedlackova L, Perkins KD, Lengyel J, Strain AK, Van Santen VL, Rice SA. 2008. Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism. Journal of Virology, 82(15): 7443-7455.
[45]	Shen GH, Wang KZ, Wang S, Cai MS, Li ML, Zheng CF. 2014. Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41. Journal of Virology, 88(20): 12163-12166.
[46]	Showalter SD, Zweig M, Hampar B. 1981. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infection and Immunity, 34(3): 684-692.
[47]	Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, Oberdoerffer P, Sandberg R, Oberdoerffer S. 2011. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature, 479(7371): 74-79.
[48]	Silva L, Cliffe A, Chang L, Knipe DM. 2008. Role for A-type lamins in herpesviral DNA targeting and heterochromatin modulation. PLoS Pathogens, 4(5): e1000071.
[49]	Smith S, Reuven N, Mohni KN, Schumacher AJ, Weller SK. 2014. Structure of the herpes simplex virus 1 genome: manipulation of nicks and gaps can abrogate infectivity and alter the cellular DNA damage response. Journal of Virology, 88(17): 10146-10156.
[50]	Song B, Liu JJ, Yeh KC, Knipe DM. 2000. Herpes simplex virus infection blocks events in the G1 phase of the cell cycle. Virology, 267(2): 326-334.
[51]	Taddeo B, Zhang WR, Roizman B. 2006. The UL41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins. Proceedings of the National Academy of Sciences of the United States of America, 103(8): 2827-2832.
[52]	Taddeo B, Zhang WR, Roizman B. 2013. The herpes simplex virus host shutoff RNase degrades cellular and viral mRNAs made before infection but not viral mRNA made after infection. Journal of Virology, 87(8): 4516-4522.
[53]	Taylor TJ, Knipe DM. 2004. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. Journal of Virology, 78(11): 5856-5866.
[54]	Teif VB, Beshnova DA, Vainshtein Y, Marth C, Mallm JP, Höfer T, Rippe K. 2014. Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development. Genome Research, 24(8): 1285-1295.
[55]	Volcy K, Fraser NW. 2013. DNA damage promotes herpes simplex virus-1 protein expression in a neuroblastoma cell line. Journal of Neurovirology, 19(1): 57-64.
[56]	Wang S, Long J, Zheng CF. 2012. The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1. Protein & Cell, 3(5): 372-382.
[57]	Wang XJ, Patenode C, Roizman B. 2011. US3 protein kinase of HSV-1 cycles between the cytoplasm and nucleus and interacts with programmed cell death protein 4 (PDCD4) to block apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 108(35): 14632-14636.
[58]	Wang Y, Yang Y, Wu SF, Pan S, Zhou CD, Ma YJ, Ru YX, Dong SX, He B, Zhang CZ, Cao YJ. 2014. p32 is a novel target for viral protein ICP34.5 of herpes simplex virus type 1 and facilitates viral nuclear egress. Journal of Biological Chemistry, 289(52): 35795-35805.
[59]	Weitzman MD, Carson CT, Schwartz RA, Lilley CE. 2004. Interactions of viruses with the cellular DNA repair machinery. DNA Repair, 3(8-9): 1165-1173.
[60]	Weitzman MD, Weitzman JB. 2014. What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host & Microbe, 15(3): 283-294.
[61]	Wilkinson DE, Weller SK. 2004. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. Journal of Virology, 78(9): 4783-4796.
[62]	Wilkinson DE, Weller SK. 2006. Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection. Journal of Cell Science, 119(Pt 13): 2695-2703.
[63]	Wysocka J, Herr W. 2003. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends in Biochemical Sciences, 28(6): 294-304.
[64]	Yun MH, Hiom K. 2009. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature, 459(7245): 460-463.
[65]	Zaborowska J, Baumli S, Laitem C, O'reilly D, Thomas PH, O'Hare P, Murphy S. 2014. Herpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation. PloS One, 9(9): e107654.
[66]	Zhou Q, Li TD, Price DH. 2012. RNA polymerase II elongation control. Annual Review of Biochemistry, 81: 119-143.
[67]	Zhou YH, Liang YB, Pang W, Qin WH, Yao ZH, Chen X, Zhang CY, Zheng YT. 2014. Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission. BMC Infectious Diseases, 14: 463.